Treace Medical Concepts, Inc.
TMCI
$7.47
-$0.23-2.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -49.18M | -52.99M | -55.74M | -61.52M | -63.68M |
| Total Depreciation and Amortization | 8.43M | 7.97M | 7.42M | 7.45M | 6.86M |
| Total Amortization of Deferred Charges | 1.30M | 1.30M | 1.30M | 797.00K | 798.00K |
| Total Other Non-Cash Items | 38.37M | 37.26M | 35.29M | 30.78M | 29.09M |
| Change in Net Operating Assets | -13.82M | -19.29M | -25.43M | -9.94M | -3.16M |
| Cash from Operations | -14.90M | -25.75M | -37.17M | -32.43M | -30.10M |
| Capital Expenditure | -14.25M | -11.21M | -11.59M | -10.77M | -11.41M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.28M | 40.93M | 46.97M | 47.73M | 47.20M |
| Cash from Investing | 4.03M | 29.72M | 35.38M | 36.96M | 35.80M |
| Total Debt Issued | 983.00K | -- | -- | -- | -- |
| Total Debt Repaid | -98.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 300.00K | 495.00K | 428.00K | 549.00K | 8.20M |
| Repurchase of Common Stock | -446.00K | -432.00K | -268.00K | -250.00K | -250.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -7.50M |
| Cash from Financing | 739.00K | 63.00K | 160.00K | 299.00K | 450.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.13M | 4.04M | -1.63M | 4.83M | 6.15M |